China

China Map

Your location: China - Yunnan - Industry--KUNMING BIOMED INTERNATIONAL

  • Company: KUNMING BIOMED INTERNATIONAL

  • Contact:

  • Telephone number:

  • Industry: Laboratory

  • Address: 1 Boda Road, Chenggong New District Kunming, Yunnan, 650500 China

  • E-mail:

  • Company category:

  • Number Of Employees:

  • Website Address:

  • Last updated: 2026-03-23

Taxpayer No:

Revenue:

Company Introduction:

Kunming Biomed International provides NHP disease models for pharmacological studies for all kind of metabolic diseases, but also for NCS related diseases as well as eye diseases and immune & inflammatory diseases. Funded in the year 2006, KBI got its full AAALAC accreditation in 2011 and kicked-off its CRO business in 2013. Since then KBI continues its successful development, based on many years of metabolic research and support with related co-morbidities as NASH, Cardiovascular and Kidney Diseases. With TriApex group joining in 2021, KBI offers a comprehensive service from early target engagement pharmacology studies, biomarker analysis, histo-pathology until pharmacokinetic, toxicology studies, drug ADMEs, and bioanalytical tests. KBI developed throughout the years a worldwide network to most of pharmaceutical and biotech companies, referencing for excellent scientific and service related support, improving the success rate and closing the gap between pre-clinical and clinical research.

Products: